Table 2.
Diseases and systemic medications used on a regular basis among 36 OLP women at the initial clinical examination.
| Systemic disease or condition | Number of cases |
|---|---|
| Diabetes mellitus | 4 |
| Hypothyroidism | 4 |
| Mitral valve prolapse or palpitation | 4 |
| Arterial hypertension | 3 |
| Allergic disorders | 2 |
| Rheumatoid arthritis | 1 |
| Osteoporosis | 1 |
|
| |
| Medication category | Number of uses in each category |
|
| |
| Antihypertensives | 8 |
| Hormones | 5 |
| Oral hypoglycemic agents | 4 |
| Vitamin + mineral | 4 |
| NSAIDs | 3 |
| Antidepressants | 3 |
| Lipid-regulating agents | 3 |
| Insulin | 2 |
| Proton pump inhibitors | 2 |
| Bisphosphonates | 1 |
| Minor tranquilizers | 1 |
| Drugs with potential to cause LDEr* | 12** |
OLP: oral lichen planus; NSAIDs: nonsteroidal anti-inflammatory drugs; LDEr: lichenoid drug eruption.
*An etiologic category of lichen planus caused by use of systemic medications.
**Isolated medications with number of uses inside parentheses in 11 patients: propranolol (5), captopril (1), NSAIDs (4), and metformin (2).